1型神经纤维瘤病儿童眶/眶周丛状神经纤维瘤:多学科照护建议
1型神经纤维瘤病(NF1)儿童可发生累及眼睑、眼眶、眶周和面部的丛状神经纤维瘤(OPPN),导致视力丧失和外观改变。2013年9月,来自三级医疗中心的多学科工作组召开会议,针对OPPN儿童缺乏临床照护指南的问题,制定眼科监测、治疗指征及生物治疗等方面的共识建议。
要点
- OPPN可导致儿童显著视力丧失及突眼、上睑下垂和面部畸形等外观改变。
- 该共识提供眼科监测建议并列出OPPN治疗指征及即将开展的生物治疗。
- 共识讨论在该复杂疾病中开展临床试验所面临的挑战。
核心结论
- 该共识声明提供了眼科监测建议,列出了治疗指征和即将开展的生物治疗,并讨论了在该复杂疾病中开展临床试验的挑战。
研究设计与样本
- 2013年9月召集了由具有OPPN儿童照护经验的三级医疗中心儿科执业医师组成的多学科工作组。
主要发现
- OPPN可导致儿童显著视力丧失,并可继发于突眼、上睑下垂和面部畸形导致外观显著改变,引起社交尴尬和自尊下降。
- 目前尚无针对OPPN儿童的正式临床照护建议,也无公认的OPPN治疗指征标准或最佳治疗方案。
- 缺乏统一代表视觉或美学后遗症的结局指标,使循证研究和可行临床试验的设计复杂化。
临床怎么用
- 眼科医师应参与OPPN儿童的多学科照护,该共识提供了眼科监测建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: Children and adults with neurofibromatosis type 1 (NF1), a common autosomal dominant condition, manifest a variety of ophthalmologic conditions. Plexiform neurofibromas (PNs) involving the eyelid, orbit, periorbital, and facial structures (orbital-periorbital plexiform neurofibroma [OPPN]) can result in significant visual loss in children. Equally important, OPPNs can cause significant alteration in physical appearance secondary to proptosis, ptosis, and facial disfigurement, leading to social embarrassment and decreased self-esteem. CLINICAL RELEVANCE: Although NF1 is a relatively common disease in which routine ophthalmologic examinations are required, no formal recommendations for clinical care of children with OPPNs exist. Although medical and surgical interventions have been reported, there are no agreed-on criteria for when OPPNs require therapy and which treatment produces the best outcome. METHODS: Because a multidisciplinary team of specialists (oculofacial plastics, pediatric ophthalmology, neuro-ophthalmology, medical genetics, and neuro-oncology) direct management decisions, the absence of a uniform outcome measure that represents visual or aesthetic sequelae complicates the design of evidence-based studies and feasible clinical trials. RESULTS: In September 2013, a multidisciplinary task force, composed of pediatric practitioners from tertiary care centers experienced in caring for children with OPPN, was convened to address the lack of clinical care guidelines for children with OPPN. CONCLUSIONS: This consensus statement provides recommendations for ophthalmologic monitoring, outlines treatment indications and forthcoming biologic therapy, and discusses challenges to performing clinical trials in this complicated condition.
引用
- Avery RA, Katowitz JA, Fisher MJ, et al. Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care. Ophthalmology. 2016. PMID: 27817916. doi:10.1016/j.ophtha.2016.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。